Aurobindo Pharma Stock Price Analysis and Quick Research Report. Is Aurobindo Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aurobindo Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aurobindo Pharma has a PE ratio of 32.5879701854741 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aurobindo Pharma has ROA of 5.7495% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aurobindo Pharma has a Current ratio of 1.1817.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aurobindo Pharma has a ROE of 8.6782%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aurobindo Pharma has a Debt to Equity ratio of 0.2252 which means that the company has low proportion of debt in its capital.

• Sales growth: Aurobindo Pharma has reported revenue growth of 2.7021% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aurobindo Pharma for the current financial year is 23.3924798551215%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aurobindo Pharma is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aurobindo Pharma is Rs 34.0371. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aurobindo Pharma in Ticker for free. Also, one can get the intrinsic value of Aurobindo Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aurobindo Pharma FAQs

Q1. What is Aurobindo Pharma share price today?
Ans: The current share price of Aurobindo Pharma is Rs 1109.2.

Q2. What is the market capitalisation of Aurobindo Pharma?
Ans: Aurobindo Pharma has a market capitalisation of Rs 64422.51602316 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aurobindo Pharma?
Ans: The PE ratio of Aurobindo Pharma is 32.5879701854741 and the P/B ratio of Aurobindo Pharma is 3.05417834837568, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aurobindo Pharma share?
Ans: The 52-week high share price of Aurobindo Pharma is Rs 1592, and the 52-week low share price of Aurobindo Pharma is Rs 1010.

Q5. Does Aurobindo Pharma pay dividends?
Ans: Currently, Aurobindo Pharma does not pay dividends. Dividend yield of Aurobindo Pharma is around 0%.

Q6. What are the face value and book value of Aurobindo Pharma shares?
Ans: The face value of Aurobindo Pharma shares is Rs 1, while the book value per share of Aurobindo Pharma is around Rs 363.1746. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aurobindo Pharma?
Ans: Aurobindo Pharma has a total debt of Rs 4625.09 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aurobindo Pharma?
Ans: The ROE of Aurobindo Pharma is 8.6782% and ROCE of Aurobindo Pharma is 10.8532%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aurobindo Pharma a good buy for the long term?
Ans: The Aurobindo Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aurobindo Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aurobindo Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aurobindo Pharma’s financials?
Ans: You can review Aurobindo Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.